Skip to content


Femara (letrozole) is a small molecule pharmaceutical. Letrozole was first approved as Femara on 1997-07-25. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.
Trade Name Femara
Common Name Letrozole
Indication breast neoplasms
Drug Class Aromatase inhibitors (imidazole/triazole derivatives)
Get full access now